Bacillus Calmette–Guérin Immunotherapy for Cancer

Bacillus Calmette–Guérin (BCG), an attenuated vaccine from Mycobacterium bovis, was initially developed as an agent for vaccination against tuberculosis. BCG proved to be the first successful immunotherapy against established human bladder cancer and other neoplasms. The use of BCG has been shown to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Vaccines (Basel)
Autors principals: Cardillo, Fabíola, Bonfim, Maiara, da Silva Vasconcelos Sousa, Periela, Mengel, José, Ribeiro Castello-Branco, Luiz Roberto, Pinho, Rosa Teixeira
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8147207/
https://ncbi.nlm.nih.gov/pubmed/34062708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9050439
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars